305 related articles for article (PubMed ID: 26607484)
1. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy.
Scott LJ
Drugs; 2015 Dec; 75(18):2143-54. PubMed ID: 26607484
[TBL] [Abstract][Full Text] [Related]
2. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
[TBL] [Abstract][Full Text] [Related]
3. Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy.
Hoy SM
CNS Drugs; 2018 May; 32(5):473-484. PubMed ID: 29785508
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
[TBL] [Abstract][Full Text] [Related]
5. Lacosamide: a review of its use as adjunctive therapy in the management of partial-onset seizures.
Hoy SM
CNS Drugs; 2013 Dec; 27(12):1125-42. PubMed ID: 24203890
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
7. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
[TBL] [Abstract][Full Text] [Related]
8. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.
Chung S; Ben-Menachem E; Sperling MR; Rosenfeld W; Fountain NB; Benbadis S; Hebert D; Isojärvi J; Doty P
CNS Drugs; 2010 Dec; 24(12):1041-54. PubMed ID: 21090838
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
[TBL] [Abstract][Full Text] [Related]
10. [The experience treatment of adjunctive lacosamide for patients with drug-resistance partial epilepsy].
Kissin MY; Bondarenko II
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):23-8. PubMed ID: 24107876
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
[TBL] [Abstract][Full Text] [Related]
12. Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study.
Wechsler RT; Li G; French J; O'Brien TJ; D'Cruz O; Williams P; Goodson R; Brock M;
Epilepsia; 2014 Jul; 55(7):1088-98. PubMed ID: 24915838
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210
[TBL] [Abstract][Full Text] [Related]
14. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
Harris JA; Murphy JA
Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
[TBL] [Abstract][Full Text] [Related]
16. Lacosamide as adjunctive therapy for partial-onset epileptic seizures: a review of the clinical and economic literature.
Simoens S
Curr Med Res Opin; 2011 Jul; 27(7):1329-38. PubMed ID: 21561394
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures.
Ben-Menachem E
Drugs Today (Barc); 2008 Jan; 44(1):35-40. PubMed ID: 18301802
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.
Ben-Menachem E; Biton V; Jatuzis D; Abou-Khalil B; Doty P; Rudd GD
Epilepsia; 2007 Jul; 48(7):1308-17. PubMed ID: 17635557
[TBL] [Abstract][Full Text] [Related]
19. Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.
Becerra JL; Ojeda J; Corredera E; Ruiz Giménez J
CNS Drugs; 2011 Dec; 25 Suppl 1():3-16. PubMed ID: 22141347
[TBL] [Abstract][Full Text] [Related]
20. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.
Steinhoff BJ; Eckhardt K; Doty P; De Backer M; Brunnert M; Schulze-Bonhage A
Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
